MCAL Therapeutics Inc.

Pharmaceutical company · San Francisco, California, United States

MCAL Therapeutics Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $449,994 sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

MCAL Therapeutics at a glance

Typepharmaceutical company

HeadquartersSan Francisco, California, United States

Earliest incorporation on record2020

SEC CIK1812100

What does MCAL Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $449,994 sold (2020).

Frequently asked questions about MCAL Therapeutics

Where is MCAL Therapeutics headquartered?

MCAL Therapeutics Inc. is headquartered in San Francisco, California, United States.

What does MCAL Therapeutics do?

MCAL Therapeutics Inc. is a pharmaceutical company.

When was MCAL Therapeutics founded?

The earliest incorporation on record for MCAL Therapeutics Inc. is in 2020, according to public company registers.

Similar companies

Kyntra Bio, Inc.San Francisco, California, United States
Nektar TherapeuticsSan Francisco, California, United States
Olema Pharmaceuticals, Inc.San Francisco, California, United States
GT Biopharma, Inc.San Francisco, California, United States
Delpor, Inc.San Francisco, California, United States
Jaguar Health, Inc.San Francisco, California, United States
Silver Creek Pharmaceuticals, Inc.San Francisco, California, United States
Amarantus Bioscience Holdings, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences